U.S. Markets closed

KaloBios Pharmaceuticals, Inc. (KBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.20-0.05 (-2.22%)
At close: 9:53AM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development10,44916,72126,573
Selling General and Administrative8,37614,29610,145
Non Recurring-3,3353,335
Total Operating Expenses---
Operating Income or Loss-18,825-34,352-36,718
Income from Continuing Operations
Total Other Income/Expenses Net-8,063-184-66
Earnings Before Interest and Taxes-18,700-34,536-36,784
Interest Expense1318421,214
Income Before Tax-18,831-35,378-37,998
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-27,019-35,378-37,998
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-27,019-35,378-37,998
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-27,019-35,378-37,998